Please login to the form below

Not currently logged in
Email:
Password:

Global Pricing Innovations and Partners4Access partner on market access

Will collaborate on orphan drug pricing and access solutions

Global Pricing Innovations and Partners4AccessGlobal Pricing Innovations and Partners4Access have formed a strategic partnership to offer pricing and access solutions for orphan drugs.

Together, the pricing and global access experts drugs hope to provide an strong specialist service offering creative market access strategies for the pharmaceutical industry.

The partnership will utilise data analytics and modeling to assess and calibrate these solutions, pooling expertise from both organisations.

Founder and chief executive of Global Pricing Innovations Preeti Patel, said: “When two companies share similar values, it is a great foundation for a strategic partnership.

“The common vision we share in creating innovative price and access solutions for our clients makes the partnership an obvious choice.
“Our combined knowledge and strengths will promote synergy and ensure high quality service to all our clients.”

Cementing the collaboration, the two firms will move their respective global headquarters to a shared site in Euston, London, with the collective team supported by an offshore presence in Asia.

Managing partner of the Holland-based Partners4Access Sophie Schmitz, said: “The choice of London as a headquarters is important for us to be close to our European and US clients.

“London has long been a hub of innovation for the pharmaceutical industry.”

Article by
Rebecca Clifford

30th September 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics